These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27137853)

  • 1. [Not Available].
    Dollfus H
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():5-7. PubMed ID: 27137853
    [No Abstract]   [Full Text] [Related]  

  • 2. [Towards a better organisation of care for rare diseases in France : a ministry perspective].
    Chevrier A
    Med Sci (Paris); 2018 May; 34 Hors série n°1():9-10. PubMed ID: 29911544
    [No Abstract]   [Full Text] [Related]  

  • 3. ["Orphan diseases"--the orphans of medicine].
    Schenk M
    Dtsch Med Wochenschr; 2010 Apr; 135(16):p15. PubMed ID: 20669526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rare Diseases].
    Weber S; Grüters-Kieslich A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 May; 60(5):477-478. PubMed ID: 28421247
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current status of the French National Data Repository in the field of Rare Diseases].
    Salamanca E
    Med Sci (Paris); 2018 May; 34 Hors série n°1():26. PubMed ID: 29911550
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methodology and management of clinical trials with small number of patients for rare diseases].
    Micallef J
    Presse Med; 2012 May; 41 Suppl 1():S32-4. PubMed ID: 22483773
    [No Abstract]   [Full Text] [Related]  

  • 7. [Not Available].
    Guillevin L
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():19-22. PubMed ID: 27137857
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renewal of Filnemus: ambitious goals for 2019-2023].
    Attarian S; Salort-Campana E
    Med Sci (Paris); 2019 Nov; 35 Hors série n° 2():5-6. PubMed ID: 31859622
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in Rare Diseases Research 2010-2016: An IRDiRC Perspective.
    Dawkins HJS; Draghia-Akli R; Lasko P; Lau LPL; Jonker AH; Cutillo CM; Rath A; Boycott KM; Baynam G; Lochmüller H; Kaufmann P; Le Cam Y; Hivert V; Austin CP;
    Clin Transl Sci; 2018 Jan; 11(1):11-20. PubMed ID: 28796411
    [No Abstract]   [Full Text] [Related]  

  • 10. [Not Available].
    Med Sci (Paris); 2016 Apr; 32 Spec No 1():8-11. PubMed ID: 27137854
    [No Abstract]   [Full Text] [Related]  

  • 11. Future of Rare Diseases Research 2017-2027: An IRDiRC Perspective.
    Austin CP; Cutillo CM; Lau LPL; Jonker AH; Rath A; Julkowska D; Thomson D; Terry SF; de Montleau B; Ardigò D; Hivert V; Boycott KM; Baynam G; Kaufmann P; Taruscio D; Lochmüller H; Suematsu M; Incerti C; Draghia-Akli R; Norstedt I; Wang L; Dawkins HJS;
    Clin Transl Sci; 2018 Jan; 11(1):21-27. PubMed ID: 28796445
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rare diseases are not orphan any longer].
    Cordier JF
    Rev Prat; 2012 Jan; 62(1):3. PubMed ID: 22335057
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rare diseases, a public health issue].
    Donnart A; Viollet V; Roinet-Tournay M
    Soins Pediatr Pueric; 2013; (274):17-9. PubMed ID: 24228329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [French Health Authority guide].
    Bouvenot G; Dubernard JM; Rochaix L
    Therapie; 2012; 67(5):407. PubMed ID: 23241249
    [No Abstract]   [Full Text] [Related]  

  • 15. [Orphanet, an information site on rare diseases].
    Aymé S
    Soins; 2003; (672):46-7. PubMed ID: 12655825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rare diseases: an "exceptional field of research. Interview by Catherine Holué].
    Dolfus H; Lévy N
    Rev Prat; 2012 Jan; 62(1):89-90. PubMed ID: 22335076
    [No Abstract]   [Full Text] [Related]  

  • 17. [State of play of innovative experimentations in telemedicine].
    Espinoza P
    Med Sci (Paris); 2018 May; 34 Hors série n°1():33-35. PubMed ID: 29911556
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not Available].
    Jabot F; Laurent A
    Sante Publique; 2018; 30(2):155-156. PubMed ID: 30148302
    [No Abstract]   [Full Text] [Related]  

  • 19. [The organization of pharmacovigilance in France, in Europe and worldwide - From label to delivery of an innovative treatment: what a journey! (3)].
    Lebrun-Vignes B
    Med Sci (Paris); 2019 Mar; 35 Hors série n° 1():37-39. PubMed ID: 30943161
    [No Abstract]   [Full Text] [Related]  

  • 20. Health Administration (Quality Assurance Committees) Amendment Bill 1989, New South Wales.
    Aust Clin Rev; 1990; 10(1):19-21. PubMed ID: 2078146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.